Vimarsana
Biggest News Aggregation in the World

Page 19 - Revenue Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Revenue Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Revenue Code Today - Breaking & Trending Today

The US Corporate Transparency Act: Practical Considerations For Private Fund Sponsors As The Effective Date Approaches - Securities - Vimarsana News

The US Corporate Transparency Act: Practical Considerations For Private Fund Sponsors As The Effective Date Approaches - Securities

Earlier this year, the US Congress passed the Corporate Transparency Act (CTA). The CTA will require thousands of privately held US and non-US entities to report beneficial ownership...

Source: mondaq.com
ELDORADO GOLD : AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN - Form 6-K -December 15, 2023 at 02:17 pm EST - Vimarsana News

ELDORADO GOLD : AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN - Form 6-K -December 15, 2023 at 02:17 pm EST

ELDORADO GOLD CORPORATION AMENDED AND RESTATED PERFORMANCE SHARE UNIT PLAN for Designated Participants as approved by Shareholders as of June 10,...

Tax Court Hampers Funds' Ability To Exclude Income Of Non-Passive Limited Partners From Self-Employment Net Earnings - Income Tax - Vimarsana News

Tax Court Hampers Funds' Ability To Exclude Income Of Non-Passive Limited Partners From Self-Employment Net Earnings - Income Tax

In Soroban Capital Partners LP v. Commissioner,[1]the Tax Court held that the statutory exclusion from the imposition of self-employment tax does not automatically apply...

Source: mondaq.com
Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K -December 14, 2023 at 04:41 pm EST - Vimarsana News

Bellicum Pharmaceuticals : 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 - Form 8-K -December 14, 2023 at 04:41 pm EST

Bellicum Pharmaceuticals, Inc. 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 Dear Stockholders of Bellicum Pharmaceuticals, Inc.: ...

The US Corporate Transparency Act: Practical Considerations for Private Fund Sponsors as the Effective Date Approaches | K&L Gates LLP - Vimarsana News

The US Corporate Transparency Act: Practical Considerations for Private Fund Sponsors as the Effective Date Approaches | K&L Gates LLP

Earlier this year, the US Congress passed the Corporate Transparency Act (CTA). The CTA will require thousands of privately held US and non-US entities to report beneficial ownership to...